Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.

El Zarif T, Abou Alaiwi S, Nassar AH, Gariazzo E, Santo V, Garbo E, Aldea M, Paoloni F, Pannu S, Semaan K, Chehab O, Hoballah M, Navani V, Gao Y, Meyers D, Stukalin I, Mittra A, Li M, Jones N, Grynberg S, Shapira R, Vasbinder A, Hayek SS, Bou Farhat E, Eid M, Saad E, Freeman D, Parikh K, Desai A, Smith C, El-Am E, Nana FA, Foderaro S, Baena J, Herrera M, Cortellini A, Pinato DJ, Korolewicz J, Kim C, Sackstein P, Denu RA, Macaron W, Abdel-Wahab N, Neilan TG, Lima JAC, Florez N, Janne P, Ricciuti B, Pecci F, Choueiri TK, Kwan JM, Naqash AR

Open source

DOI
10.1093/oncolo/oyag277
Published
2026 Aug 6
Container
The oncologist
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyag277,
  title = {Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.},
  author = {El Zarif T and Abou Alaiwi S and Nassar AH and Gariazzo E and Santo V and Garbo E and Aldea M and Paoloni F and Pannu S and Semaan K and Chehab O and Hoballah M and Navani V and Gao Y and Meyers D and Stukalin I and Mittra A and Li M and Jones N and Grynberg S and Shapira R and Vasbinder A and Hayek SS and Bou Farhat E and Eid M and Saad E and Freeman D and Parikh K and Desai A and Smith C and El-Am E and Nana FA and Foderaro S and Baena J and Herrera M and Cortellini A and Pinato DJ and Korolewicz J and Kim C and Sackstein P and Denu RA and Macaron W and Abdel-Wahab N and Neilan TG and Lima JAC and Florez N and Janne P and Ricciuti B and Pecci F and Choueiri TK and Kwan JM and Naqash AR},
  year = {2026},
  journal = {The oncologist},
  doi = {10.1093/oncolo/oyag277},
  url = {https://doi.org/10.1093/oncolo/oyag277}
}

RIS

TY  - JOUR
TI  - Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.
AU  - El Zarif T
AU  - Abou Alaiwi S
AU  - Nassar AH
AU  - Gariazzo E
AU  - Santo V
AU  - Garbo E
AU  - Aldea M
AU  - Paoloni F
AU  - Pannu S
AU  - Semaan K
AU  - Chehab O
AU  - Hoballah M
AU  - Navani V
AU  - Gao Y
AU  - Meyers D
AU  - Stukalin I
AU  - Mittra A
AU  - Li M
AU  - Jones N
AU  - Grynberg S
AU  - Shapira R
AU  - Vasbinder A
AU  - Hayek SS
AU  - Bou Farhat E
AU  - Eid M
AU  - Saad E
AU  - Freeman D
AU  - Parikh K
AU  - Desai A
AU  - Smith C
AU  - El-Am E
AU  - Nana FA
AU  - Foderaro S
AU  - Baena J
AU  - Herrera M
AU  - Cortellini A
AU  - Pinato DJ
AU  - Korolewicz J
AU  - Kim C
AU  - Sackstein P
AU  - Denu RA
AU  - Macaron W
AU  - Abdel-Wahab N
AU  - Neilan TG
AU  - Lima JAC
AU  - Florez N
AU  - Janne P
AU  - Ricciuti B
AU  - Pecci F
AU  - Choueiri TK
AU  - Kwan JM
AU  - Naqash AR
PY  - 2026
JO  - The oncologist
DO  - 10.1093/oncolo/oyag277
UR  - https://doi.org/10.1093/oncolo/oyag277
ER  -

APA

T, E. Z., S, A. A., AH, N., E, G., V, S., E, G., M, A., F, P., S, P., K, S., O, C., M, H., V, N., Y, G., D, M., I, S., A, M., M, L., N, J., S, G., R, S., A, V., SS, H., E, B. F., M, E., E, S., D, F., K, P., A, D., C, S., E, E., FA, N., S, F., J, B., M, H., A, C., DJ, P., J, K., C, K., P, S., RA, D., W, M., N, A., TG, N., JAC, L., N, F., P, J., B, R., F, P., TK, C., JM, K., & AR, N. (2026). Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.. The oncologist. https://doi.org/10.1093/oncolo/oyag277

Source records